(Q67900163)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1828764%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Effects of doxazosin and atenolol on the fibrinolytic system in patients with hypertension and elevated serum cholesterol (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1828764%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference

4 December 2022

author name string

J. H. Jansson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1828764

4 December 2022

B. Johansson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1828764

4 December 2022

K. Boman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1828764

4 December 2022

T. K. Nilsson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1828764

4 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1828764

4 December 2022

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1828764%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

http://link.springer.com/content/pdf/10.1007/BF00265838.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00265838/fulltext.html

4 December 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF00265838

4 December 2022

1 reference

European Journal of Clinical Pharmacology

4 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1828764%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1828764%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

321-326

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1828764%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1828764%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00265838

19 September 2019

exact match

0 references

cites work

Effect of treatment of hyperlipidaemia on haemostatic variables

1 reference

12 December 2020

Increased occurrence of left ventricular thrombi during early treatment with timolol in patients with acute myocardial infarction

1 reference

12 December 2020

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

12 December 2020

Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease

1 reference

12 December 2020

Risk factors for myocardial infarction in the Stockholm prospective study. A 14-year follow-up focussing on the role of plasma triglycerides and cholesterol

1 reference

12 December 2020

Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease

1 reference

12 December 2020

The effect of beta-blockade on platelet function and fibrinolytic activity

1 reference

12 December 2020

Treatment of mild hypertension: a five year controlled drug trial. The Oslo study

1 reference

12 December 2020

Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction

1 reference

12 December 2020

Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg

1 reference

12 December 2020

Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. Hypertension Detection and Follow-up Program Cooperative Group

1 reference

12 December 2020

Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study

1 reference

12 December 2020

Interrelationships between plasma levels of plasminogen activator inhibitor, tissue plasminogen activator, lipoprotein (a), and established cardiovascular risk factors in a north Swedish population

1 reference

12 December 2020

MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party

1 reference

12 December 2020

Beta-adrenergic receptor mediated release of tissue plasminogen activator in anaesthetized dogs.

1 reference

12 December 2020

Adrenergic effects on plasma lipoprotein metabolism. Speculation on mechanisms of action

1 reference

12 December 2020

Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction

1 reference

12 December 2020

Hypertriglyceridaemia and hypercoagulability

1 reference

12 December 2020

The survival of treated hypertensive patients and their causes of death: a report from the DHSS hypertensive care computing project (DHCCP)

1 reference

12 December 2020

Plasminogen activator release during venous stasis and exercise as determined by a new specific assay

1 reference

12 December 2020

Impaired fibrinolysis in coronary artery disease

1 reference

12 December 2020

Cardiovascular risk factors in the Northern Sweden MONICA Study

1 reference

12 December 2020

[Fibrinolytic system of the blood in ischemic heart disease associated with arterial hypertension in middle-aged and elderly patients]

1 reference

12 December 2020

Serum triglycerides--an independent risk factor for myocardial infarction but not for angina pectoris

1 reference

12 December 2020

Glycaemic control, smoking habits and diabetes duration affect the extrinsic fibrinolytic system in type I diabetic patients but microangiopathy does not.

1 reference

12 December 2020

Age dependence of tissue plasminogen activator concentrations in plasma, as studied by an improved enzyme-linked immunosorbent assay

1 reference

12 December 2020

Platelet adhesiveness, plasma fibrinogen and fibrinolytic activity in cases of essential hypertension

1 reference

12 December 2020

Increased fibrinolytic potential after diet intervention in healthy coronary high-risk individuals.

1 reference

12 December 2020

A 24-week multicenter double-blind study of doxazosin and hydrochlorothiazide in patients with mild to moderate essential hypertension

1 reference

12 December 2020

Mortality in patients of the Glasgow Blood Pressure Clinic

1 reference

12 December 2020

Plasminogen activator inhibitor in the blood of patients with coronary artery disease

1 reference

12 December 2020

Comparative effects of doxazosin and hydrochlorothiazide on serum lipids and blood pressure in essential hypertension

1 reference

12 December 2020

An enzyme linked immunosorbent assay for determination of tissue plasminogen activator applied to patients with thromboembolic disease

1 reference

12 December 2020

[Status of fibrinolysis and the reactivity of thrombocytes in patients with hypertension and coronary arteriosclerosis]

1 reference

12 December 2020

Diurnal variation of the fibrinolytic system

1 reference

12 December 2020

Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction

1 reference

12 December 2020

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

1 reference

12 December 2020

Evidence for a rapid inhibitor to tissue plasminogen activator in plasma.

1 reference

12 December 2020

ENHANCING THE FIBRINOLYTIC ACTIVITY OF THE BLOOD BY VASOACTIVE DRUGS

1 reference

12 December 2020

Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group

1 reference

12 December 2020

Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension

1 reference

12 December 2020

Why are diabetes, stomach cancer and circulatory diseases more common in Northern Sweden?

1 reference

12 December 2020

The extrinsic fibrinolytic system in survivors of myocardial infarction

1 reference

12 December 2020

Hypertension in middle-aged men. Management, morbidity and prognostic factors during long-term hypertensive care

1 reference

12 December 2020

Acta medica Scandinavica

5

702

1

O Samuelsson

1985

1 reference

The New England Journal of Medicine

4 December 2022

12

312

1127

LA Carlsson

1985

1 reference

4 December 2022

26

9

3

NB Krarup

1956

1 reference

4 December 2022

Klinicheskaia meditsina

37

64

103

AN Kartsev

1986

1 reference

4 December 2022

Klinicheskaia meditsina

38

65

74

NK Khamidov

1987

1 reference

4 December 2022

Identifiers

DOI

10.1007/BF00265838

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1828764%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

1 reference